Navigation Links
Finola Hughes Announces Her Best Accessory at Fashion Week
Date:2/4/2008

Makeover Host Shares Secrets to Better Vision and More Youthful Appearance

NEW YORK, Feb. 4 /PRNewswire/ -- Fashion expert Finola Hughes will see the latest fashion trends in high definition this year at New York's Fashion Week, thanks to Varilux(R) and Crizal(R) lenses, her new progressive lenses by Essilor. Hughes, the host of the popular Style Network television show "How Do I Look?," is spending Fashion Week viewing the latest fall styles in clothing and accessories and using the opportunity to show all women how they can take their style to the next level, encouraging them to update their looks with apparel and accessory choices that are both fashionable and functional.

Since Fashion Week is the place where style statements are made for the upcoming season, but also tend to show clothes that aren't readily available to all women, Hughes will translate the latest trends from the runway to the everyday and show women everywhere how simple it is to update their existing looks by adding fashion-forward accessories, including eyewear.

"The best fashion tip anyone can receive is to wear what both looks good and feels good on you, which certainly also applies to one's eyewear," said Hughes. "Bifocal lines and lens glares will really mess up a great look -- and squinting can't be good for your vision; women would be wise to update their eyewear along with their wardrobes this fall so they can really see and be seen."

As a master of the total wardrobe makeover, Finola knows that updating one's look is often as simple as investing in the details. In addition to eyewear that looks and feels great, Finola recommends that women:

-- Add colorful, bold enamel bangle bracelets, which are both chic and

inexpensive, and can be worn through the seasons;

-- Follow the trend and "go green" with your clothing. Buy at least one

eco-friendly piece for your wardrobe such as a tee made from recycled

fabric or
'/>"/>

SOURCE Essilor USA
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Genetics Researcher at Childrens Hospital Selected as Howard Hughes Medical Institute Investigator
2. Genetics researcher at Childrens Hospital selected as Howard Hughes Medical Institute Investigator
3. Actress Jenifer Lewis, Authors Dr. Michael Eric Dyson and Susan Taylor Among Featured Speakers for Senator Hughes Behavioral Mental Health Summit
4. UT Southwestern researcher named Howard Hughes Medical Institute investigator
5. WHNNs Bob Hughes Fitted With Hearing Aids by Mobile Care Hearing Clinic Now Serving Saginaw Area
6. PA Commission for Women Announces Shocking Pink Osteoporosis Campaign in Rural PA
7. QED International Associates Announces Changes to the HealthShares(TM) Diagnostics Index
8. Perrigo Company Authorizes Continuation of Share Repurchase Program and Announces Quarterly Dividend
9. The UV Foundation Announces February is Vitamin D Deficiency Month
10. Webcast Alert: Oscient Pharmaceuticals Announces Date for Release of Fourth Quarter Financial Results
11. QED International Associates Announces Changes to the HealthShares(TM) European Medical Products and Devices Index
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... Sonoran Vein and Endovascular nurse, ... Distinguished Preceptorship Award from The American Association ... the advancement of nurse practitioners. The Distinguished Preceptorship ... had made a significant contribution toward increasing the ... of Nurse Practitioners (AANP) is the largest full-service ...
(Date:11/26/2014)... Nov. 25, 2014 (HealthDay News) -- Youngsters who enter ... new study suggests. Early puberty was linked with ... poor self-image and high anxiety levels, according to the ... such as conflict with family and peers, and having ... study found. Although the study found an association ...
(Date:11/26/2014)... TUESDAY, Nov. 25, 2014 (HealthDay News) -- Teens ... likely to abuse those drugs than other teens, ... the need to conduct substance abuse assessments on ... researchers said. "Prescribers and parents don,t realize ... a professor at the University of Michigan School ...
(Date:11/26/2014)... 25, 2014 (HealthDay News) -- Exposure to peanut protein ... allergy in infants with the skin condition eczema, a ... children in the United States are allergic to peanuts. ... food allergies, particularly peanut allergy, the researchers noted. ... to 15 months. The researchers examined the amount of ...
(Date:11/26/2014)... Randy Dotinga HealthDay Reporter ... drugs such as Prilosec and Nexium may disrupt the makeup ... of infections and other problems, a small new study suggests. ... it more likely users will become ill, and study authors ... inhibitors. However, these antacids "should be used at the ...
Breaking Medicine News(10 mins):Health News:Sonoran Nurse Receives Distinguished Preceptorship Award from The American Association of Nurse Practitioners 2Health News:Early Puberty Linked to Increased Risk of Depression in Teens 2Health News:Teens Given Anxiety, Sleep Meds May Be at Risk for Drug Abuse 2Health News:Infants With Eczema May Be More Prone to Peanut Allergy: Study 2Health News:Could Popular Heartburn Drugs Upset Your 'Good' Gut Bugs? 2Health News:Could Popular Heartburn Drugs Upset Your 'Good' Gut Bugs? 3
... patients with the blood cancer , , WEDNESDAY, July 9 ... once-banned drug thalidomide for patients with myeloma have learned ... is to science: Don,t judge results too early. , ... increased the odds of a complete remission, but not ...
... Weight Watchers,International, Inc. (NYSE: WTW ) will release ... close on Thursday, July 31, 2008., The Company ... at 5:00,p.m. ET. During the conference call, David Kirchhoff, ... Officer, will discuss,second quarter results and answer questions from ...
... its,efforts to ensure the State,s leaders are putting patients ... for Patient Care (CPC), a,non-profit, patient-advocacy organization, hand delivered ... as other key leaders in the,State Legislature today., ... with a better,understanding of how devastating these massive health ...
... be done without destroying embryo , , WEDNESDAY, July 9 ... in developing human embryonic stem cells earlier in the ... embryo, so the whole embryo is not destroyed. , ... European Society of Human Reproduction & Embryology annual conference ...
... Pain Centers (SCPC) have been shown to perform better ... for Medicare and Medicaid Services (CMS) as compared to ... an Emory University researcher. , The findings, ... for observation medicine in the Emory University School of ...
... Holdings, Inc.,(NYSE and SWX: ZMH) announced today its second ... live over the Internet on,Thursday, July 24, 2008, at ... results will be made available at 7:00 a.m. the,morning ... can be accessed via Zimmer,s Investor Relations,website at ...
Cached Medicine News:Health News:Thalidomide Continues to Show Benefits Against Myeloma 2Health News:Thalidomide Continues to Show Benefits Against Myeloma 3Health News:Weight Watchers Announces Second Quarter 2008 Earnings Conference Call 2Health News:CPC Hand-Delivers Patient Testimonies to State Leaders Pleading for No Budget Cuts to Health and Human Services 2Health News:New Technique Harvests Stem Cells at Earlier Stage 2Health News:New Technique Harvests Stem Cells at Earlier Stage 3Health News:Chest pain center accreditation linked with better outcomes in heart attack patients 2
(Date:11/26/2014)...  Medtronic,s roughly $43 billion acquisition and ... in the media for its US Federal tax ... player in one of the fastest growing device ... research firm said  the two companies compete in ... of solutions spanning inpatient to home care, and ...
(Date:11/26/2014)... -- Unilife Corporation (NASDAQ: UNIS, ASX: UNS), a designer, manufacturer ... that its Chairman and CEO, Alan Shortall , ... Annual Healthcare Conference at the New York Palace Hotel ... The conference presentation will be broadcast ... To listen, please go to: http://ir.unilife.com/events.cfm . An ...
(Date:11/26/2014)... OAKS, Calif. and LONDON , ... ) and AstraZeneca (NYSE: AZN ) today announced ... evaluating two doses of brodalumab in more than 1,800 patients ... with both Stelara ® (ustekinumab) and placebo at week ... brodalumab weight-based analysis group were each shown to be superior ...
Breaking Medicine Technology:Medtronic - Covidien: Beyond Taxes, Deal Will Create Patient Monitoring Power, according to Kalorama Information 2Medtronic - Covidien: Beyond Taxes, Deal Will Create Patient Monitoring Power, according to Kalorama Information 3Unilife to Present at the Piper Jaffray 26th Annual Healthcare Conference on December 2nd 2Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 2Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 3Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 4Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 5Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 6Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 7Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 8Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 9Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 10
Intermittent catheter...
Intermittent catheter...
Intermittent catheter...
... proBNP assay is a rapid and accurate bedside ... system assisting the diagnosis and assessment of patients ... both speed and accuracy profit from ... proBNP assay = 12 minutes. In emergency departments ...
Medicine Products: